Brinsupri (aka Brensocatib)
FDA approved Brensocatib today. Hooray for us. Let’s hope we have access to it as soon as possible and it gives us some measure of relief. Thank you to all the scientists and doctors and patients!
https://www.multivu.com/insmed/9347351-en-fda-approves-brinsupri-brensocatib
Interested in more discussions like this? Go to the MAC & Bronchiectasis Support Group.
Great info, thanks.
I have heard via the Lung Matters Facebook page that some (1 or 2) people on the trial have had to have all their teeth pulled after using this drug. Just something to be aware of...as a side effect.
I must have read the same post. Someone commented (and my pulmonologist confirmed) that it may be have been due to Papillon–Lefèvre syndrome (PLS) is a very rare inherited disorder caused by mutations in the CTSC gene.
It is characterized by:
Thickened, scaly skin on the palms and soles (palmoplantar keratoderma)
Severe early-onset gum disease (periodontitis)
Premature loss of both baby and adult teeth
It usually begins in early childhood and is linked to a deficiency of the enzyme cathepsin C (DPP1).
When taking Brinsupri regular dental checks are imperative, every 3-6 months.
Thank you, Scoop. Appreciate that.
Hi Ling
Did your friends report on the benefits to them after 2 years on it?
They said that it helped to cut down exacerbations.
Ling
Thanks for that comment Scoop.
(Sigh) "That" page immediately posted a boogy man story in response to a new drug therapy that could be a game changer for many people. Yes, it has side effects as do all drugs. We all need to read, ask questions and educate ourselves before taking something one person posted at face value. Follow the science.
So are you saying that this very rare genetic disorder was the cause of the one or two cases? That seems highly coincidental and unlikely. If it is a known possible side effect (gum disease) and they were in the trial it seems obvious to be caused by Brensocatib.
No, I am not saying that. In reality, there could be other contributing factors (dental health at time of trial, age, other medications, environmental factors, etc.) Rare things do happen even in clinical trials.
The rare genetic condition creates a deficiency of DPPI and Brensocatib lowers ones DPPI. Logically it would seem that is the cause of those cases along with a likely predisposition to gum disease.